Indications for: MENQUADFI
Adults and Children:
<2yrs: not established. Give by IM inj only. Primary vaccination: ≥2yrs: 0.5mL once as single inj. Booster vaccination: ≥15yrs: may give a single (0.5mL) dose for those at continued risk, if at least 4yrs have elapsed since the prior dose.
Severe allergic reaction after a previous dose of MenQuadfi or any other tetanus toxoid-containing vaccine.
Not for the prevention of N. meningitidis serogroup B disease. Not a substitute for routine tetanus immunization. Have epinephrine inj (1:1000) available. History of Guillain-Barre syndrome. Immunosuppressed. Complement deficiency. Eculizumab therapy. Risk of syncope. Pregnancy. Nursing mothers.
Immunosuppressants may get suboptimal response. Concomitant other vaccines: see full labeling.
Inj site reactions (pain, erythema, swelling), myalgia, headache, malaise.
To enroll pregnant patients or obtain information call (800) 822-2463.
Generic Drug Availability: